Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
Persons affected by leprosy should be encouraged and supported to form self-help groups, ideally with other persons with disabilities or facing social exclusion. Initiatives should be taken to nurture, support and strenghen the capacity of regional and national community-based organ-izations and network, enabling persons affected by leprosy to engage and influnce decision-makers at all levels.
Dr. Poonam Khetrapal Singh
Regional Director,
WHO South East Asia
Sponsor
Patient Safety Capsules
India needs to invest in affordable innovation, support innovative start ups for growth: Expert
New Delhi, January 28, 2022: India needs to invest in affordable innovation and embrace entrepreneurship as an economic model of growth and backing innovative start-ups as a model to create economic and employment growth, says Upadhyayula Suryana-rayana Murty, director, National Institute of Pharmaceutical Education & Research (NIPER)- Guwahati.
Health ministry amends Drug Rules to include liquid antiseptic under Schedule K
New Delhi, January 27, 2022: The Union health ministry has issued a final amendment to include liquid antiseptics for household use under the Schedule K of Drugs Rules, 1945 exempting the product category from the requirement of sale license.
Drug Laws & Policy Injections
Ayush ministry issues draft document of 20 harmonized monographs in ASU&H systemsNew Delhi, February 1, 2022: The Union Ministry of Ayush has issued a draft document of 20 harmonized monographs in the Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) systems seeking comments from the stakeholders.
Indian pharma sees US FDA norms on ANDA labeling can prevent false labelling issues Bengaluru, February 1, 2022: Indian pharma sees that the US FDA guidance calling for ANDA (abbreviated new drug application) labelling updates following revision of the RLD labeling can prevent false labeling issues.
DRiefcase Becomes NHA-Approved PHR App for Ayushman Bharat Digital Mission DeploymentNew Delhi, January 31, 2022: This integration will now allow users to create their own Ayushman Bharat Health Account (or ABHA address) and ensure that created medical records are issued to the correct person or accessed by a health information user only after obtaining the appropriate consent.
Gcci wants Gst reduced in health insuranceAhmedabad, February 1, 2022: Since the onset of Covid-19 disease, health insurance has become an important asset for businesses. While the industry is facing rising prices, the Gujarat Chamber of Commerce and Industry (GCC) on Monday issued a statement to the Union Finance Minister calling for a GST cut on health insurance. from 18% to 5%.
Enforcement of drug laws partially halted in Kerala as 60 staff members down with Covid-19Chennai, January 27, 2022: The third wave of the Covid-19 pandemic has badly hit the operations of the drugs control administration in Kerala, especially in the state headquarters in Thiruvananthapuram.
NPPA panel seeks clarification on license status from manufacturers of clotrimazole 1% mouth paintNew Delhi, January 31, 2022: The multidisciplinary committee of experts, under the National Pharmaceutical Pricing Authority (NPPA), has said that it would desire to get a clarification of approval of license status from the manufacturers and markets of antifungal medication clotrimazole 1% mouth paint, in connection with fixation of ceiling price for the drug under the regulation.
Pharma Injections
Railroad Hospital, Health Center Integrated with Ayushman Bharat Digital MissionNew Delhi, January 30, 2022: 695 hospitals and health centers on railroads across the country said Saturday that they had successfully integrated with the Ayushman Bharat Digital Mission (ABDM), according to a statement by RailTel, who carried out the project. 
Demand growth for hospital supplies in Tier II cities in India outperforms Tier I: JD Mart Consumer InsightsJanuary 29, 2022: At the national level, demand for hospital supplies grew the most at 55% year-on-year, while demand for pathology and operating room instruments remained stable.
Icmr approves Covid Test Kit Made In State Bhubaneswar, January 29, 2022: The Rapid Antigen Test (RAT) kit, developed in collaboration with the Center for Regional Medical Research (RMRC) by a Bhubaneswar-based company to support the Make-in-Odisha initiative, has been approved by the Indian Medical Research Council. I did. Used to detect Covid-19.
Sun Pharma gets SEC nod for phase III clinical trial for antipsychotic drug pimavanserin New Delhi, January 27, 2022: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has granted permission to Sun Pharma Ltd to conduct phase III clinical trial for its antipsychotic drug pimavanserin in India.
DoP invites third round of applications for leftover slots under PLI Scheme for domestic bulk drug manufacturing New Delhi, January 31, 2022: The Department of Pharmaceuticals (DoP) has issued a notice inviting applications from eligible companies to set up facilities under the production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical key starting materials (KSMs), drug intermediates (DI) and active pharmaceutical ingredients (APIs) for the third time for the leftover slots in the scheme.
Merck’s COVID-19 pill is effective against Omicron in lab studies January 29, 2022: Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday that six laboratory studies showed that the experimental oral COVID-19 drug molnupiravir was effective against the rapidly spreading oculomicrons.
Drug Dopes
e-RUPI enables easy healthcare access to last mile with digital techBengaluru, January 29, 2022: India’s digital technology with e-RUPI has enabled seamless payment for healthcare. The government has come up with several schemes which allow specialist medical care to be accessible to the last mile, by way of digital delivery of healthcare services, stated Abhishek Malhotra, managing partner, TMT Law Practice . 
CCMB researchers develop new equipments and methods to detect different forms of Covid variants in advanceHyderabad, January 28, 2022: Researchers at the Centre for Cellular and Molecular Biology (CCMB) in Hyderabad have developed new equipment and methods to detect various variants of coronavirus in advance and alert public and policy makers about the precautionary measures to be taken to curb the spread of the deadly disease.
Industry urges IPC to defer implementation of monograph of Ferrous Ascorbate IP 2018 addendum 2021 till June 2022 Mumbai, January 27, 2022: In a bid to ensure availability and supply of Ferrous Ascorbate API and its formulation in domestic market amid rising cases of Covid-19 and its Omicron variant, the drug industry has urged the Indian Pharmacopoeia Commission (IPC) to defer the implementation of monograph of Ferrous Ascorbate IP 2018 Addendum 2021 till June 30, 2022.
Medicines on the public market are no different: experts Nagpur, January 31, 2022: Although the government has given permission to the common market for Covid Covishield and Covaxin canes for use in the adult population under certain conditions, experts believe the move will not change.
PVC producers don’t want to change import tariffs January 29, 2022: Domestic producers of polyvinyl chloride (PVC) are afraid that tariff cuts could hinder the planned addition of domestic capacity, so the government will leave import tariffs on materials within budget. I hope to keep it.
High expectations for the medical device industryJanuary 29, 2021: The MedTech industry maintained its patience and determination throughout the 2021 roller coaster ride. It was the MedTech industry that was responsible for the fight against pandemics for most of the pandemics in the absence of a proven vaccine.
National Injections
Karnataka DC dept gets Rs. 4 crore from Centre-State funds for sterile modular cleanroom Bengaluru, January 27, 2022: In an effort to accelerate drug testing, the Karnataka drugs control department has received a fund allocation of Rs. 4 crore from the Centre and State to strengthen the analysis of sterile injectables.
Lack of supervision by DC authorities leads to selling of outdated medicines in TelanganaHyderabad, January 31, 2022: With complete lack of supervision of pharmacies and medical shops in Telangana, the situation has reached to a level where the pharmacies in some of the remote and rural areas are resorting to selling outdated drugs to the gullible patients, thus risking their lives.
Bihar IPA wants state govt to authorize in-service pharmacists to prescribe medicines for minor ailments Patna, February 1, 2022: Prompted by the need, ‘access to healthcare for all’ and by fear of the current Omicron spread, the Bihar state branch of the Indian Pharmaceutical Association (Bihar IPA) has urged the state government to allow in-service pharmacists in the primary health centres (PHCs) to prescribe medicines for minor ailments and injuries to patients in the absence of doctors.
Among the key suggestions for tax incentives, diagnostic accessibility, PPP New Delhi, January 30, 2022: Testing is a viable component and the first line of defense against COVID as it helps track and isolate positive cases to control the spread of the virus. The emergence of COVID and many other illnesses highlighted the importance of diagnostic segments to ensure that appropriate treatment was provided according to the patient’s condition.
India provides 3 tonnes of medical assistance to Afghanistan January 30, 2022: India will supply Afghanistan with 3 tonnes of essential life-saving medicine in the fourth batch of medical assistance to war-torn countries, and in the coming weeks, more humanitarian to Afghanistan in the form of medicines and edible grains. We plan to provide support. The office said on Saturday. In a statement, the MEA stated that India has promised to continue its special relationship with the people of Afghanistan and provide humanitarian assistance.
Cancer Tumors in Male Face Removed in Scarless Surgery at Delhi Hospital New Delhi, January 30, 2022: using innovative technology, doctors surgically resected a tumor from the face of a 46-year-old cancer patient in a “scarless surgery” at a private facility here, hospital officials claim Friday did. A team of doc-tors approached his oral cavity by making four small holes, 8 mm each, under the patient’s collarbone. They said his cancer appeared as an ulcer on the lower right cheek and tongue.
Global Injections
U.S. COVID-19 Cases Falling, Hospitalizations PeakingJanuary 28, 2022: The average number of daily COVID-19 cases is falling nationwide in the U.S., and hospitalizations seem to be nearing a peak. The daily average on Thursday was about 590,000 cases, according to the data tracker by The New York Times, marking a 27% decline from two weeks ago.
FDA Grants Full Approval to Moderna COVID-19 VaccineJanuary 31, 2022: Moderna announced today that its mRNA COVID-19 vaccine has received full FDA approval for adults 18 years and older. The move lifts an FDA emergency use authorization for the vaccine, which started Dec. 18, 2020. The Moderna vaccine also now has a new trade name: Spikevax.
Studies show that SARS-CoV-2 may remain active for longer than the recom-mended quarantine period
Washington, January 29, 2022: A new study found that SARS-CoV-2, the virus that causes COVID-19, can infect humans for more than 200 days in atypical cases.
AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests
January 31, 2022: AstraZeneca China last month met with government officials as part of an investigation into alleged insur-ance fraud, the company said Friday. The probe—and subsequent arrests—hinge on suspicions that AZ China staff members tampered with genetic testing results of cancer patients in order to defraud medical insurance funds, China's National Healthcare Security Administration (NHSA) said in its release.
Unable to 'align' with FDA, Regeneron, Sanofi pull application for Libtayo in cer-vical cancer days before decision date
January 28, 2022: With a Jan. 30 target date fast approaching for approval of Libtayo as a second-line treatment in cervical cancer, Regeneron and Sanofi have voluntarily withdrawn their application.
Beijing reports spike in new virus cases
Janaury 30, 2022: Beijing has reported its highest number of Covid-19 cases in 18 months, five days ahead of the start of the Winter Olympics in the Chinese capital.
PSAIIF PILL
IPC flags safety alert against nonsteroidal anti-inflammatory drug, ibuprofen
umbai, February 1, 2022: The Indian Pharmacopoeia Commission (IPC), which is the National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI), has flagged drug safety alert revealing that ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) which is used to treat pain and inflammatory diseases, is linked with adverse event known as fixed drug eruption.
Ayush practitioners are also eligible to issue fitness certificates as per NCISM Act: NCISM chairman
New Delhi, January 28, 2022: Chairman of the National Commission for Indian System of Medicine (NCISM) Vaidya Jayant Deopujari has categorically said that Ayush practitioners are also legally eligible to issue medical fitness certificates as per provisions of the NCISM Act 2020.
Frequently Asked Questions
How do I choose a sustainable medical waste disposal company? IIT Delhi researchers show the way
New Delhi: Researchers at the Indian Institute of Technology (IIT) have developed a real-time decision support framework to help hospitals choose sustainable medical waste treatment companies. According to the team, hospitals that have difficulty disposing of medical waste in a hygienic and sustainable man-ner can use the proposed decision support framework to select the right company. Read More>>>
SUBSCRIBER'S SYMPTOM
Prioritizing NTDs is the only way to eliminate NTDs.Global expert
January 31, 2022: In the process of tackling the COVID-19 pandemic, we must not allow the outbreak of the greater crisis of disruption of efforts to prevent and eradicate Neglected Tropical Diseases (NTD), which affects approximately 1 billion people worldwide. not. This is most important from speakers in a global panel discussion co-sponsored by the Leprosy Mission Trust India (TLMTI), the Sasakawa Health Foundation (SHF), Disabled People’s International (DPI) and the National Center for the Promotion of Employment of Persons with Disabilities (NCPEDP). Message. Today is World NTD Day and World Leprosy Day.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Mr Prakash Gosain, MD Very good e-newsletter that is interesting and enjoyable to read.
Ms Disha Singh, Pharma expertAll the editions I have read so far are extremely insightful and capture the events in the Pharma world very well. Keep up the good work.
Mr Manohar Bhatt, MBBS
Like to read articles in the publications that are sent twice every month. Congrats to the Pre-scription team.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
